RXRX – Recursion Pharmaceuticals, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Fair Value
Margin Of Safety %
Put/Call OI Ratio
0.55
Float Short %
26.54
EPS 1 Diff
-0.07
EPS Year Diff
-0.04
Ticker: RXRX
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2024-09-06 | RXRX | 5.91 | 0.57 | 0.26 | 132828 |
2024-09-09 | RXRX | 6.03 | 0.56 | 0.86 | 133037 |
2024-09-10 | RXRX | 6.31 | 0.55 | 0.86 | 132682 |
2024-09-11 | RXRX | 6.45 | 0.54 | 1.29 | 132307 |
2024-09-12 | RXRX | 6.5 | 0.53 | 0.84 | 131031 |
2024-09-13 | RXRX | 6.58 | 0.52 | 0.49 | 130343 |
2024-09-16 | RXRX | 6.65 | 0.51 | 0.57 | 130547 |
2024-09-17 | RXRX | 6.76 | 0.51 | 0.16 | 130729 |
2024-09-18 | RXRX | 6.9 | 0.51 | 0.21 | 130884 |
2024-09-19 | RXRX | 6.93 | 0.51 | 0.55 | 131906 |
2024-09-20 | RXRX | 6.8 | 0.51 | 1.00 | 131818 |
2024-09-23 | RXRX | 6.68 | 0.56 | 0.13 | 89915 |
2024-09-24 | RXRX | 6.82 | 0.55 | 0.52 | 90824 |
2024-09-25 | RXRX | 6.89 | 0.56 | 0.40 | 92116 |
2024-09-26 | RXRX | 7.16 | 0.56 | 0.21 | 93916 |
2024-09-27 | RXRX | 6.98 | 0.55 | 0.29 | 94720 |
2024-09-30 | RXRX | 6.6 | 0.55 | 0.22 | 95283 |
2024-10-01 | RXRX | 6.18 | 0.55 | 0.74 | 96046 |
2024-10-02 | RXRX | 6.11 | 0.56 | 0.36 | 97936 |
2024-10-03 | RXRX | 6.08 | 0.55 | 0.18 | 100122 |
2024-10-04 | RXRX | 6.11 | 0.55 | 0.45 | 100790 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2024-09-06 | RXRX | 5.92 | 18.6 | - | -1.62 |
2024-09-09 | RXRX | 6.11 | 18.6 | - | -1.62 |
2024-09-10 | RXRX | 6.32 | 18.6 | - | -1.62 |
2024-09-11 | RXRX | 6.45 | 18.6 | - | -1.62 |
2024-09-12 | RXRX | 6.50 | 18.6 | - | -1.62 |
2024-09-13 | RXRX | 6.57 | 18.6 | - | -1.62 |
2024-09-16 | RXRX | 6.65 | 18.6 | - | -1.62 |
2024-09-17 | RXRX | 6.79 | 18.6 | - | -1.62 |
2024-09-18 | RXRX | 6.90 | 18.6 | - | -1.62 |
2024-09-19 | RXRX | 6.94 | 18.6 | - | -1.62 |
2024-09-20 | RXRX | 6.80 | 18.6 | - | -1.62 |
2024-09-23 | RXRX | 6.67 | 18.6 | - | -1.62 |
2024-09-24 | RXRX | 6.83 | 18.6 | - | -1.62 |
2024-09-25 | RXRX | 6.88 | 18.6 | - | -1.62 |
2024-09-26 | RXRX | 7.17 | 18.6 | - | -1.62 |
2024-09-27 | RXRX | 6.98 | 18.6 | - | -1.62 |
2024-09-30 | RXRX | 6.59 | 18.6 | - | -1.62 |
2024-10-01 | RXRX | 6.18 | 18.6 | - | -1.62 |
2024-10-02 | RXRX | 6.12 | 18.6 | - | -1.62 |
2024-10-03 | RXRX | 6.06 | 18.6 | - | -1.62 |
2024-10-04 | RXRX | 6.12 | 18.6 | - | -1.62 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2024-09-06 | RXRX | -1.49 | 3.80 | 25.14 |
2024-09-09 | RXRX | -1.43 | 3.80 | 25.14 |
2024-09-10 | RXRX | -1.43 | 3.80 | 25.14 |
2024-09-11 | RXRX | -1.43 | 3.80 | 25.13 |
2024-09-12 | RXRX | -1.43 | 3.80 | 26.01 |
2024-09-13 | RXRX | -1.55 | 3.80 | 25.65 |
2024-09-16 | RXRX | -1.47 | 3.80 | 25.65 |
2024-09-17 | RXRX | -1.47 | 3.80 | 25.65 |
2024-09-18 | RXRX | -1.47 | 3.80 | 25.65 |
2024-09-19 | RXRX | -1.47 | 3.80 | 25.65 |
2024-09-20 | RXRX | -1.49 | 3.80 | 25.65 |
2024-09-23 | RXRX | -1.43 | 3.80 | 25.13 |
2024-09-24 | RXRX | -1.43 | 3.80 | 25.13 |
2024-09-25 | RXRX | -1.43 | 3.80 | 26.54 |
2024-09-26 | RXRX | -1.42 | 3.80 | 26.54 |
2024-09-27 | RXRX | -1.42 | 3.80 | 26.54 |
2024-09-30 | RXRX | -1.42 | 3.80 | 26.54 |
2024-10-01 | RXRX | -1.43 | 3.80 | 26.54 |
2024-10-02 | RXRX | -1.33 | 3.80 | 26.54 |
2024-10-03 | RXRX | -1.33 | 3.80 | 26.54 |
2024-10-04 | RXRX | -1.33 | 3.80 | 26.54 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.4
Avg. EPS Est. Current Quarter
-0.35
Avg. EPS Est. Next Quarter
-0.47
Insider Transactions
-1.33
Institutional Transactions
3.8
Beta
0.81
Average Sales Estimate Current Quarter
30
Average Sales Estimate Next Quarter
14
Fair Value (Academic)
Quality Score
28
Growth Score
48
Sentiment Score
2
Actual DrawDown %
85.7
Max Drawdown 5-Year %
Target Price
10.14
P/E
Forward P/E
PEG
P/S
35.45
P/B
2.94
P/Free Cash Flow
EPS
-1.62
Average EPS Est. Cur. Y
-1.62
EPS Next Y. (Est.)
-1.79
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-755.37
Relative Volume
0.75
Return on Equity vs Sector %
-85.8
Return on Equity vs Industry %
-106.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
stock quote shares RXRX – Recursion Pharmaceuticals, Inc. Stock Price stock today
news today RXRX – Recursion Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RXRX – Recursion Pharmaceuticals, Inc. yahoo finance google finance
stock history RXRX – Recursion Pharmaceuticals, Inc. invest stock market
stock prices RXRX premarket after hours
ticker RXRX fair value insiders trading